Cathy N Lam
Examiner (ID: 12915)
Most Active Art Unit | 2811 |
Art Unit(s) | 4122, 2811 |
Total Applications | 430 |
Issued Applications | 305 |
Pending Applications | 0 |
Abandoned Applications | 125 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9166793
[patent_doc_number] => 08592472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-26
[patent_title] => 'Co-crystals'
[patent_app_type] => utility
[patent_app_number] => 13/120897
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 13617
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 575
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120897
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/120897 | Co-crystals | Sep 21, 2009 | Issued |
Array
(
[id] => 6465880
[patent_doc_number] => 20100190755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND RELATED METHODS OF TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/563923
[patent_app_country] => US
[patent_app_date] => 2009-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24194
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190755.pdf
[firstpage_image] =>[orig_patent_app_number] => 12563923
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/563923 | TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND RELATED METHODS OF TREATMENT | Sep 20, 2009 | Abandoned |
Array
(
[id] => 6360927
[patent_doc_number] => 20100087546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'USE OF DIMETHYL SULFONE (MSM) TO REDUCE HOMOCYSTEINE LEVELS'
[patent_app_type] => utility
[patent_app_number] => 12/562942
[patent_app_country] => US
[patent_app_date] => 2009-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5231
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20100087546.pdf
[firstpage_image] =>[orig_patent_app_number] => 12562942
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/562942 | USE OF DIMETHYL SULFONE (MSM) TO REDUCE HOMOCYSTEINE LEVELS | Sep 17, 2009 | Abandoned |
Array
(
[id] => 6368467
[patent_doc_number] => 20100074939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'HARMINE COMPOUNDS FOR PROMOTING BONE GROWTH'
[patent_app_type] => utility
[patent_app_number] => 12/562498
[patent_app_country] => US
[patent_app_date] => 2009-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12142
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20100074939.pdf
[firstpage_image] =>[orig_patent_app_number] => 12562498
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/562498 | HARMINE COMPOUNDS FOR PROMOTING BONE GROWTH | Sep 17, 2009 | Abandoned |
Array
(
[id] => 7685272
[patent_doc_number] => 20100120869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'COMPOUNDS AND METHODS FOR PKC THETA INHIBITION'
[patent_app_type] => utility
[patent_app_number] => 12/561750
[patent_app_country] => US
[patent_app_date] => 2009-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9752
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120869.pdf
[firstpage_image] =>[orig_patent_app_number] => 12561750
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/561750 | Compounds and methods for PKC theta inhibition | Sep 16, 2009 | Issued |
Array
(
[id] => 5958566
[patent_doc_number] => 20110182953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'POLYMORPHIC FORM OF CALCIUM ACAMPROSATE'
[patent_app_type] => utility
[patent_app_number] => 13/120992
[patent_app_country] => US
[patent_app_date] => 2009-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2025
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182953.pdf
[firstpage_image] =>[orig_patent_app_number] => 13120992
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/120992 | POLYMORPHIC FORM OF CALCIUM ACAMPROSATE | Sep 3, 2009 | Abandoned |
Array
(
[id] => 6083722
[patent_doc_number] => 20110144055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'Health Care'
[patent_app_type] => utility
[patent_app_number] => 12/671072
[patent_app_country] => US
[patent_app_date] => 2009-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5849
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144055.pdf
[firstpage_image] =>[orig_patent_app_number] => 12671072
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671072 | Health Care | Sep 3, 2009 | Abandoned |
Array
(
[id] => 5464528
[patent_doc_number] => 20090324728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING AMORPHOUS BENZIMIDAZOLE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/553409
[patent_app_country] => US
[patent_app_date] => 2009-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4764
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324728.pdf
[firstpage_image] =>[orig_patent_app_number] => 12553409
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/553409 | PHARMACEUTICAL COMPOSITIONS COMPRISING AMORPHOUS BENZIMIDAZOLE COMPOUNDS | Sep 2, 2009 | Abandoned |
Array
(
[id] => 6576025
[patent_doc_number] => 20100129448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'TOPICAL HYDROGEL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/542925
[patent_app_country] => US
[patent_app_date] => 2009-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5384
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129448.pdf
[firstpage_image] =>[orig_patent_app_number] => 12542925
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/542925 | TOPICAL HYDROGEL COMPOSITION | Aug 17, 2009 | Abandoned |
Array
(
[id] => 6113744
[patent_doc_number] => 20110190352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'USE OF DABIGATRANETEXILATE FOR TREATING PATIENTS WITH PULMONARY HYPERTENSION'
[patent_app_type] => utility
[patent_app_number] => 13/058937
[patent_app_country] => US
[patent_app_date] => 2009-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3229
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190352.pdf
[firstpage_image] =>[orig_patent_app_number] => 13058937
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/058937 | USE OF DABIGATRANETEXILATE FOR TREATING PATIENTS WITH PULMONARY HYPERTENSION | Aug 16, 2009 | Abandoned |
Array
(
[id] => 6636670
[patent_doc_number] => 20100035846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'METHOD FOR THE TREATMENT OF ACNE AND CERTAIN DOSAGE FORMS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/536359
[patent_app_country] => US
[patent_app_date] => 2009-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4561
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035846.pdf
[firstpage_image] =>[orig_patent_app_number] => 12536359
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/536359 | Method for the treatment of acne and certain dosage forms thereof | Aug 4, 2009 | Issued |
Array
(
[id] => 6496610
[patent_doc_number] => 20100010084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'HIGH PENETRATION PRODRUG COMPOSITIONS OF RETINOIDS AND RETINOID-RELATED COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/503739
[patent_app_country] => US
[patent_app_date] => 2009-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16997
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20100010084.pdf
[firstpage_image] =>[orig_patent_app_number] => 12503739
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/503739 | High penetration prodrug compositions of retinoids and retinoid-related compounds | Jul 14, 2009 | Issued |
Array
(
[id] => 5495450
[patent_doc_number] => 20090263478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'CARVEDILOL FORMS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/500199
[patent_app_country] => US
[patent_app_date] => 2009-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15155
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263478.pdf
[firstpage_image] =>[orig_patent_app_number] => 12500199
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/500199 | CARVEDILOL FORMS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF | Jul 8, 2009 | Abandoned |
Array
(
[id] => 6167959
[patent_doc_number] => 20110196037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'USE OF NITRATED LIPIDS FOR TREATMENT OF SIDE EFFECTS OF TOXIC MEDICAL THERAPIES'
[patent_app_type] => utility
[patent_app_number] => 12/996848
[patent_app_country] => US
[patent_app_date] => 2009-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3761
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20110196037.pdf
[firstpage_image] =>[orig_patent_app_number] => 12996848
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/996848 | Use of nitrated lipids for treatment of side effects of toxic medical therapies | Jun 17, 2009 | Issued |
Array
(
[id] => 6392772
[patent_doc_number] => 20100303911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'Hydrogel systems'
[patent_app_type] => utility
[patent_app_number] => 12/457079
[patent_app_country] => US
[patent_app_date] => 2009-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9844
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0303/20100303911.pdf
[firstpage_image] =>[orig_patent_app_number] => 12457079
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/457079 | Hydrogel systems | May 31, 2009 | Abandoned |
Array
(
[id] => 8410381
[patent_doc_number] => 08273778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-25
[patent_title] => 'Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth'
[patent_app_type] => utility
[patent_app_number] => 12/430610
[patent_app_country] => US
[patent_app_date] => 2009-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 31
[patent_no_of_words] => 29149
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12430610
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/430610 | Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth | Apr 26, 2009 | Issued |
Array
(
[id] => 5929943
[patent_doc_number] => 20110039902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'PROCESS FOR PREPARING A CRYSTALLINE FORM COMPOUND OF 3-BENZYL-2-METHYL-2,3,3a,4,5,6,7,7a-OCTAHYDROBENZO[d]ISOXAZOL-4-ONE'
[patent_app_type] => utility
[patent_app_number] => 12/989069
[patent_app_country] => US
[patent_app_date] => 2009-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3431
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039902.pdf
[firstpage_image] =>[orig_patent_app_number] => 12989069
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989069 | PROCESS FOR PREPARING A CRYSTALLINE FORM COMPOUND OF 3-BENZYL-2-METHYL-2,3,3a,4,5,6,7,7a-OCTAHYDROBENZO[d]ISOXAZOL-4-ONE | Apr 22, 2009 | Abandoned |
Array
(
[id] => 5929946
[patent_doc_number] => 20110039905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'BENZIMIDAZOLE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS'
[patent_app_type] => utility
[patent_app_number] => 12/989443
[patent_app_country] => US
[patent_app_date] => 2009-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9601
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039905.pdf
[firstpage_image] =>[orig_patent_app_number] => 12989443
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989443 | BENZIMIDAZOLE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Apr 22, 2009 | Abandoned |
Array
(
[id] => 6432655
[patent_doc_number] => 20100152226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'SUSTAINED RELEASE IMPLANT FOR GRANISETRON'
[patent_app_type] => utility
[patent_app_number] => 12/426721
[patent_app_country] => US
[patent_app_date] => 2009-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 2909
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152226.pdf
[firstpage_image] =>[orig_patent_app_number] => 12426721
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/426721 | Sustained release implant for granisetron | Apr 19, 2009 | Issued |
Array
(
[id] => 5496492
[patent_doc_number] => 20090264520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'LIPID-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/426034
[patent_app_country] => US
[patent_app_date] => 2009-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17911
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264520.pdf
[firstpage_image] =>[orig_patent_app_number] => 12426034
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/426034 | LIPID-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF | Apr 16, 2009 | Abandoned |